A univariate analysis of the association between GPR17 expression and overall survival in LGG and GBM demonstrated GPR17 expression to be a strong predictive biomarker of improved survival in both the TCGA and CGGA datasets (p = 6 × 10−4 and 0, respectively) (Figure 1C). This evidence concerns the gene GPR17 and glioblastoma.